F. & A. PHARMA will not infringe patent or other intellectual property rights assigned to other parties while performing any of the range of services offered.
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Any liability for patent infringement is at the buyer’s risk.
Products currently covered by valid patents are offered for R&D use under research exemption in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law in Canada; (vi) Section 68B of the Patents Act of 1953 in New Zealand; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries. Any patent infringement issue and resulting liability is solely at buyer’s risk.